D12.6
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Non-pretreated, non-pedunculated laterally spreading tumour (LST) granular type homogenous or non-granular type = 20mm in the colorectum, willingness and ability to participate in the FU of the study, availability of informed consent and a signed consent form.
Exclusion criteria
Exclusion criteria: Morphologically certain sessile-serrated lesion or LST nodular-mixed type, macroscopically probable, suspected or histologically proven malignancy, maximum polyp diameter >5cm, unability to give consent, pregnancy, known coagulation disorder, non-pausable anticoagulant therapy with double (in favour of single) antiplatelet therapy, an adenosine diphosphate receptor antagonist, direct oral anticoagulant, Marcumar or heparin therapy, presence of chronic inflammatory bowel disease, inadequate bowel preparation, ASA score IV-V
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Residual adenoma in the 6th months-follow up endoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of major complications (= perforations and/or clinically relevant postendoscopic bleedings), intraprocedural bleedings, postpolypectomy syndromes, technically successful procedures and macroscopically complete resections, intervention time, resection speed | — |
Countries
Germany
Contacts
Evangelisches Diakoniekrankenhaus Freiburg